Behcet’s disease - also known as Behcet’s syndrome - is a rare condition that causes inflammation of the blood vessels.
The most common symptoms of Behcet’s disease are:
- mouth ulcers, and
- genital ulcers.
However, Behcet’s disease can also cause inflammation of the:
- eyes,
- joints,
- skin,
- nervous system,
- veins,
- arteries,
- the heart, and
- the digestive system.
The cause of Behcet’s disease is unknown, but the immune system seems to play an important part in the development of the condition.
How common is Behcet’s disease?
Behcet’s disease seems to occur mainly in eastern Asia, the Middle East, and eastern Mediterranean.
Turkey has the highest number of cases of Behcet’s disease, where it is estimated that between 110-420 people in every 100,000 will develop it. There is also a higher than average prevalence of the condition in Japan. Behcet’s disease is rare in the UK, where it affects around 1 in 100,000.
People of Mediterranean, Middle Eastern and Asian origin are thought to be at most at risk of developing Behcet’s disease, although it can affect all ethnic groups.
Behcet's disease is more common in men than women of Mediterranean and Middle Eastern origin, but is more common in women than men of Asian origin.
The symptoms of Bechet’s disease tend to be more severe in men.
Prognosis
Behcet’s disease is a highly unpredictable health condition. Most people with the condition will experience episode where symptoms are severe followed by periods of remission. There also seems to be no identifiable triggers that cause a flare-up of symptoms.
In the most serious cases of Behcet’s disease, inflammation of the eyes can lead to permanent blindness, while inflammation of the nervous system, veins and arteries, or heart can be life-threatening. A recent study looking at Turkish patients over a 20 year period, found that almost 10% died as a result of Behcet’s disease.
There is no cure for Behcet’s disease, but it is possible to control the symptoms of the condition by using medicines that suppress the immune system (immunosuppressants).